Suppr超能文献

肿瘤相关巨噬细胞密度与甲状腺乳头状癌淋巴结转移相关。

Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma.

机构信息

Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, China.

出版信息

Thyroid. 2012 Sep;22(9):905-10. doi: 10.1089/thy.2011.0452. Epub 2012 Aug 7.

Abstract

BACKGROUND

Tumor-associated macrophages (TAMs) have recently been recognized as being important players in the tumoriogenesis of many cancers, including advanced thyroid cancer. However, a role in papillary thyroid carcinoma (PTC), the most prevalent thyroid cancer, has not been established. We hypothesized that TAMs also facilitate tumor progression in PTC.

METHODS

We investigated TAMs density in both benign thyroid lesions and PTC tumors by CD68 immunostaining. CD68-positive cell density was further associated with the clinicopathological characteristics of PTC patients. Finally, TAMs were isolated from PTC tumors and phenotyped by cytokine and receptor profiling.

RESULTS

The overall density of TAMs was found to be significantly higher in PTC tumors, compared with thyroid goiter and follicular adenoma. The density of TAMs was positively associated with lymph node metastasis in TNM (tumor-node-metastasis) stages III/VI compared with stages I/II. No association was observed in other common tumor features, including the BRAF mutation. The isolated TAMs presented with high levels of M2-associated cytokine and receptors, making M2 the predominant TAM phenotype.

CONCLUSIONS

TAMs may play a functional role in the progression of PTC.

摘要

背景

肿瘤相关巨噬细胞(TAMs)最近被认为是许多癌症发生发展的重要参与者,包括晚期甲状腺癌。然而,其在甲状腺乳头状癌(PTC)中的作用尚未确定。我们假设 TAMs 也促进 PTC 的肿瘤进展。

方法

我们通过 CD68 免疫染色来研究良性甲状腺病变和 PTC 肿瘤中的 TAMs 密度。进一步将 CD68 阳性细胞密度与 PTC 患者的临床病理特征相关联。最后,我们从 PTC 肿瘤中分离 TAMs,并通过细胞因子和受体谱对其进行表型分析。

结果

与甲状腺肿和滤泡性腺瘤相比,PTC 肿瘤中 TAMs 的总体密度明显更高。与 I/II 期相比,在 III/VI 期 TNM(肿瘤-淋巴结-转移)中 TAMs 的密度与淋巴结转移呈正相关。在其他常见肿瘤特征中,包括 BRAF 突变,未观察到相关性。分离的 TAMs 呈现出高水平的 M2 相关细胞因子和受体,使 M2 成为主要的 TAM 表型。

结论

TAMs 可能在 PTC 的进展中发挥功能作用。

相似文献

引用本文的文献

10
Harnessing Immunity to Treat Advanced Thyroid Cancer.利用免疫疗法治疗晚期甲状腺癌。
Vaccines (Basel). 2023 Dec 30;12(1):45. doi: 10.3390/vaccines12010045.

本文引用的文献

6
Prognostic utility of BRAF mutation in papillary thyroid cancer.BRAF 突变在甲状腺乳头状癌中的预后价值。
Mol Cell Endocrinol. 2010 May 28;321(1):86-93. doi: 10.1016/j.mce.2009.10.012. Epub 2009 Oct 31.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验